Harnessing Health IT for Improved Cardiovascular Risk Management


article has not abstract


Published in the journal: . PLoS Med 7(8): e32767. doi:10.1371/journal.pmed.1000313
Category: Essay
doi: 10.1371/journal.pmed.1000313

Summary

article has not abstract

Summary Points

  • Cardiovascular disease (CVD) risk management through drug, dietary, and other interventions can significantly prevent or delay CVD events.

  • Despite evidence for effectiveness, large gaps have been demonstrated between what is known and what is actually done in health care.

  • Information technology (IT) has the potential to support clinicians to close these gaps throughout processes of care delivery.

  • IT can be used to support identification of at-risk individuals, CVD risk assessment and management, care planning, patient self-management, and evaluation of improvements in care and health outcomes.

  • To achieve the potential of IT-based programmes requires a supportive social and political environment, substantial organisational changes, and active patient and clinician engagement.

Cardiovascular disease (CVD) is one of the leading causes of death and disability worldwide, accounting for 16.7 million (29.2%) of total global deaths, 80% of them taking place in low- or middle-income countries [1]. While death is inevitable, premature death and loss of productive years of life from CVD is, for the most part, preventable. Much can be achieved by population-wide interventions that seek to lower cigarette and salt consumption, obesity prevalence, and blood cholesterol levels in the entire population [2]. At a personal health level, there is an abundance of evidence that reducing modifiable CVD risk factors (smoking, lipid fractions, blood pressure, diabetes) through drug, dietary, and other interventions can prevent or delay CVD events. Almost all adults could achieve a 50%–80% relative reduction in CVD risk if they took a combination of a lipid-lowering drug, a blood pressure lowering drug, and aspirin [3]. The higher the pre-treatment CVD risk, the greater the absolute benefit and therefore the greater the cost-effectiveness of treatment [4]. Therefore, many national guidelines now advocate identifying those at high risk of a future CVD event in the short-term and tailoring the intensity of management for individuals according to their baseline CVD risk.

Is CVD Risk Reduction Happening in Practice?

Large gaps have been demonstrated between what is known to be effective and what is actually done in health care [5],[6]. Studies have shown that a formal CVD risk assessment to systematically identify high-risk patients is rarely conducted [7],[8], and audits of care indicate substantial under-use of effective CVD interventions by clinicians [9][12].

The reasons why clinicians do not follow patient management guidelines have been explored in some depth [13][15] and reflect a complex interplay of organisational, health system, provider, and patient factors. Barriers include lack of time, heavy workload and other competing demands, a lack of teamwork and organisation in the practice, paperwork, bureaucracy, and a lack of support to conduct preventive care [13][15]. Guidelines have been criticised for being too complex and focused on single diseases, whereas patients present with multiple problems. Even if clinicians have the ability, time, and resources to act on the evidence, for management to be effective the patient needs to understand and agree with the approach, be motivated to make changes, and be willing and able to adhere to a management plan.

Can Technological Innovation Help to Close the CVD Evidence-Practice Gap?

There is growing interest in the potential of information technology (IT) to reduce human error and variation in patient care. A recent systematic review has investigated the impact of a wide range of health IT [16]. Three major benefits were found for quality of care (particularly in association with preventive care):

  • increased adherence to guideline-based care;

  • enhanced surveillance and monitoring; and

  • decreased medication errors.

Table 1 shows where health IT could be used to support the process of CVD risk assessment and management in primary care practices. The focus is on tailoring interventions to specific patients based on recorded data and thus providing personalised prevention.

Tab. 1. Health IT Support for CVD Risk Assessment and Management Processes in Primary Care.
Health IT Support for CVD Risk Assessment and Management Processes in Primary Care.

Most of these technologies are predicated on

  • the presence of an electronic medical record (EMR, defined as computer-based clinical data of an individual that are location-specific and kept by a single practice or office, health centre, or ambulatory clinic [17]); and

  • the ability to register patients, query the database to identify patients of interest, and contact them.

Electronic queries to identify those eligible for CVD risk assessment and utilisation of simple rules-based automated reminder and recall systems have been increasingly used internationally since the late 1970s. Electronic calculators for estimates of CVD risk have been available since the early 1990s. However, only recently have more patient- and clinician-friendly CVD risk communication tools been developed (see Box 1 for an example).

Box 1. Example of CVD Risk Communication Tool Currently Being Used in New Zealand

Your Heart Forecast, a tool that graphically depicts absolute, relative, and long-term measures of CVD risk as well as a more accessible metric, your “cardiovascular age” or “heart age”. It also shows the benefit of risk factor reduction (http://www.yourheart.forecast.org.nz/) [35].

Computerised decision support systems (CDSSs) can rapidly and automatically convert the recommendations from evidence-based syntheses into guidance for clinicians, tailored for an individual patient's profile. Systematic reviews have found moderate evidence of CDSS effectiveness with respect to provider processes and performance, but the effects on patient outcomes are understudied and, where research has been conducted, inconsistent [18][20].

E-prescribing and e-referrals are becoming widespread in countries with a high degree of practice computerisation and Internet connectivity. The challenge is to add value to this system via more extensive two-way sharing of information. This could include notification of filled prescriptions and alerts in the practice system for un-filled prescriptions; notification of changes to care plans and medications by other providers; and missed appointments at other health services.

CDSSs can also form the basis of shared goal setting and the development of care plans for risk reduction. Instant electronic access and registration into self-management programmes removes barriers, such as having to attend another session, uses the “teachable moment” (i.e., being informed one is at high risk of an acute cardiac event) to enhance motivation, and can involve the primary care provider to motivate and tailor appropriately to the individual's risk profile. Internet-based programmes to support self-management and healthy behaviour change are proliferating. While there is limited evidence for effectiveness of IT-based self-management programmes, smoking cessation is one area that has been rigorously trialled. A recent meta-analysis of 22 randomised controlled trials found “… sufficient clinical evidence to support the use of Web- and computer-based smoking cessation programs for adult smokers” (RR 1.44, 90% confidence interval 1.27–1.64) [21]. Social networking Web sites are also being used formally and informally for such support. Patientslikeme.com is just one example of harnessing social networking to provide peer support for patients with the same conditions [22]. However, the social networking phenomenon does not easily lend itself to rigorous research of effectiveness.

Electronic patient portals or patient access to electronic health records can further empower patients to manage their disease and become active participants in their own health outcomes. However, there is limited research published on the effectiveness of these tools with respect to health outcomes, particularly for CVD.

Telehealth interventions include any telecommunications between a provider and patient between clinic visits, such as via phone, Internet, videoconference communication, and text messaging. A systematic review of telehealth interventions for the secondary prevention of coronary disease found significant differences in smoking, lipid levels, and systolic blood pressure in patients taking part in such interventions [23]. Mobile phones are likely to play an important role here in the future, allowing behaviour change support to be proactively sent directly to people wherever they are in formats from simple SMS/text messages to multimedia video messages. Such programmes can be tailored and personalised, and yet are eminently scalable to large diverse populations (see Box 2 for an example). Two recent systematic reviews of health care delivered via mobile phone found 26 studies in smoking cessation, diabetes care, physical activity, stress management, hypertension, and other conditions [24],[25]. These reviews reported significant behaviour change, with clinical and process improvements in the majority of studies.

Box 2. Example of a Mobile Phone Programme Being Used in New Zealand and the United Kingdom

Txt2quit is a free national text messaging smoking cessation programme in New Zealand that people can join by phone or online (http://www.quit.org.nz/txt2quit). It was implemented following a large randomised controlled trial which showed a doubling of short-term quit rates [36]. A similar study of this intervention, called txt2stop, is now being conducted in the UK.

Telemedicine has also taken the form of live remote specialist consultation (for patients in geographically isolated areas), or the transmission of diagnostic images/video/data for review by specialists. This also includes remote monitoring at home by devices that transmit data (e.g., ECG, blood pressure, weight, blood glucose) to a health care provider for interpretation and alterations to care. Home-based telemonitoring using Internet and mobile phone technology has been demonstrated to reduce hospital admissions for those with congestive heart failure and, if admitted, to reduce the length of stay [26],[27].

Finally, IT support is vital for monitoring processes and outcomes for clinical audit and research with pay-for-performance programmes such as the United Kingdom quality and outcomes framework based on the necessity of an “IT spine”. Health IT records are increasingly being used for CVD research, for example, to generate large risk prediction cohorts [28],[29].

What Is Needed to Implement a Systematic Technology-Based Approach for CVD?

The benefits of implementing a systematic health IT approach could include improvements in the quality of care, reduced duplication, improving access to services in areas of growing demand and limited resources, and improved monitoring and evaluation. However, while some health IT systems implementations succeed, the majority are likely to fail [30]. The greater the personal and organisational change required by a system, the greater the risk of failure. Adverse effects of health IT implementation can include increased time for direct and indirect patient care [31], the loss of privacy and confidentiality, and possible changes to the doctor–patient relationship [32]. The time commitment involved with learning and implementing new systems may be substantial. The set-up costs of computerisation and implementation of health IT can be large and require ongoing investment. Furthermore, IT is a rapidly evolving science. By the time a large-scale project is completed, technology has often moved on [33].

Key elements that facilitate the development of a systematic technology-based approach are the availability of high quality national or international CVD guidelines, and local health IT specialists with the ability to develop reliable systems and the willingness and resources to maintain, sustain, and continue to innovate in response to consumer, clinician, and local health service needs. At a national level, policies that support prevention of CVD and long-term condition management need to be aligned with national IT policies that support the development of unified informatics standards for collecting health data, coding, messaging, and network infrastructure. While privacy and confidentiality concerns remain, there is a need for mature privacy statutes and ensuring consumers are aware of the potential uses of their health data.

Without clinical and health service buy-in, no IT solution will be successful. The solutions need to be effective, user-friendly, and integrated with all other systems, and ultimately must be efficient in terms of person-time. Berg describes this as a “… process of mutual transformation …” involving organisational change and allowing for change in the IT strategy arising out of the process of implementation [34].

In summary, CVD management requires partnerships between providers and patients, between staff within an institution, between service providers in the primary care setting, and between primary, secondary, and tertiary care services. For IT to achieve the potential to close the gap between evidence and practice and translate into positive patient outcomes there needs to be teamwork and a change in the way clinicians and services work together. This is particularly important for long-term health conditions such as CVD, where there is often unbounded need in the face of limited resources.


Zdroje

1. World Health Organisation 2003 The world health report 2003 - shaping the future Geneva World Health Organisation

2. MurrayCJL

LauerJA

HutubessyRCW

NiessenL

TomijimaN

2003 Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361 717 725

3. WaldNJ

LawMR

2003 A strategy to reduce cardiovascular disease by more than 80%. BMJ 326 1419

4. JacksonR

LawesCMM

BennettDA

MilneRJ

RodgersA

2005 Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 365 434 441

5. McGlynnEA

AschSM

AdamsJ

KeeseyJ

HicksJ

2003 The quality of health care delivered to adults in the United States. New Eng J Med 348 2635 2645

6. WoolfSH

JohnsonRE

2005 The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med 3 545 552

7. MontgomeryAA

FaheyT

PetersTJ

MacIntoshC

SharpDJ

2000 Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 320 686 690

8. WellsS

FurnessS

RafterN

HornE

WhittakerR

2008 Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice. Eur J Cardiovasc Prev Rehabil 15 173 178

9. KallioV

HamalainenH

HakkilaJ

LuurilaO

1979 Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet 2 1091 1094

10. KotsevaK

WoodD

De BackerG

De BacquerD

PyoralaK

2009 EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16 121 137

11. KotsevaK

WoodD

De BackerG

De BacquerD

PyoralaK

2009 Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373 929 940

12. WebsterRJ

HeeleyEL

PeirisDP

BayramC

CassA

2009 Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust 191 324 329

13. BazianL

2005 Do evidence-based guidelines improve the quality of care? Evidence-Based Healthcare and Public Health 9 270 275

14. CabanaMD

RandCS

PoweNR

WuAW

WilsonMH

1999 Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 1458 1465

15. GrolR

GrimshawJ

2003 From best evidence to best practice: effective implementation of change in patients' care. Lancet 362 1225 1230

16. ChaudhryB

WangJ

WuS

MaglioneM

MojicaW

2006 Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 144 742 752

17. ProttiD

2007 Comparison of information technology in general practice in 10 countries. Healthcare Q 10 107 116

18. GargAX

AdhikariNKJ

McDonaldH

Rosas-ArellanoMP

DevereauxPJ

2005 Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 293 1223 1238

19. ShojaniaKG

JenningsA

MayhewA

RamsayCR

EcclesMP

2009 The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev (3) CD001096

20. SintchenkoV

MagrabiF

TipperS

2007 Are we measuring the right end-points? Variables that affect the impact of computerised decision support on patient outcomes: a systematic review. Med Inform Internet Med 32 225 240

21. MyungS-K

McDonnellDD

KazinetsG

SeoHG

MoskowitzJM

2009 Effects of Web- and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch Intern Med 169 929 937

22. FrostJH

MassagliMP

2008 Social uses of personal health information within PatientsLikeMe, an online patient community: what can happen when patients have access to one another's data. J Med Internet Res 10 e15

23. NeubeckL

RedfernJ

FernandezR

BriffaT

BaumanA

2009 Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. Eur J Cardiovasc Prev Rehabil 16 281 289

24. KrishnaS

BorenSA

BalasEA

2009 Healthcare via cell phones: a systematic review. Telemed J E Health 15 231 240

25. WhittakerR

BorlandR

BullenC

LinRB

McRobbieH

2009 Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev (4) CD006611

26. GiordanoA

ScalviniS

ZanelliE

CorraU

LongobardiGL

2009 Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol 131 192 199

27. ScherrD

KastnerP

KollmannA

HallasA

AuerJ

2009 Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial. J Med Internet Res 11 e34

28. Hippisley-CoxJ

CouplandC

VinogradovaY

RobsonJ

MayM

2007 Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335 136

29. WellsS

2008 Getting Evidence to and from general practice consultations for cardiovascular risk management using computerised decision support [PhD thesis] Auckland University of Auckland

30. HeeksR

2006 Health information systems: failure, success and improvisation. Int J Med Inform 75 125 137

31. EslamiS

Abu-HannaA

de KeizerNF

2007 Evaluation of outpatient computerized physician medication order entry systems: A systematic review. J Am Med Inform Assoc 14 400 406

32. MitchellE

SullivanF

2005 A descriptive feast but an evaluative famine: systematic review of published articles on primary care computing during 1980–97. BMJ 322 279 282

33. MeigsJB

CagleiroE

DubeyA

Murphy-SheehyP

GildesgameC

2003 A controlled trial of web-based diabetes disease management: the MGH Diabetes Primary Care Improvement Project. Diabetes Care 26 750 757

34. BergM

2001 Implementing information systems in health care organizations: myths and challenges. Int J Med Inform 64 143 156

35. WellsS

KerrA

EadieS

WiltshireC

JacksonR

2010 ‘Your Heart Forecast’: a new approach for describing and communicating cardiovascular risk? Heart 96 708 13

36. RodgersA

CorbettT

BramleyD

RiddellT

WillsM

2005 Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control 14 255 261

Štítky
Interní lékařství

Článek vyšel v časopise

PLOS Medicine


2010 Číslo 8

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Farmaceutická péče o pacienta s inhalační terapií
nový kurz
Autoři: Mgr. Ondřej Šimandl

Revmatoidní artritida: včas a k cíli
Autoři: MUDr. Heřman Mann

Jistoty a nástrahy antikoagulační léčby aneb kardiolog - neurolog - farmakolog - nefrolog - právník diskutují
Autoři: doc. MUDr. Štěpán Havránek, Ph.D., prof. MUDr. Roman Herzig, Ph.D., doc. MUDr. Karel Urbánek, Ph.D., prim. MUDr. Jan Vachek, MUDr. et Mgr. Jolana Těšínová, Ph.D.

Léčba akutní pooperační bolesti
Autoři: doc. MUDr. Jiří Málek, CSc.

Nové antipsychotikum kariprazin v léčbě schizofrenie
Autoři: prof. MUDr. Cyril Höschl, DrSc., FRCPsych.

Všechny kurzy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se